BFM
IDXX icon

Boston Financial Management’s Idexx Laboratories IDXX Stock Holding History

Boston Financial Management’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		$989K Sell
2,391
-158
-6% -$69.3K 0.03% 195
2024
Q3 		$1.29M Hold
2,549
– – 0.04% 179
2024
Q2 		$1.24M Buy
2,549
+42
+2% +$21.1K 0.04% 180
2024
Q1 		$1.35M Sell
2,507
-200
-7% -$109K 0.04% 171
2023
Q4 		$1.5M Hold
2,707
– – 0.05% 156
2023
Q3 		$1.18M Buy
2,707
+220
+9% +$110K 0.04% 163
2023
Q2 		$1.25M Hold
2,487
– – 0.05% 171
2023
Q1 		$1.24M Sell
2,487
-3
-0.1% -$1.44K 0.05% 161
2022
Q4 		$1.02M Buy
2,490
+8
+0.3% +$3.1K 0.04% 179
2022
Q3 		$809K Buy
2,482
+1
+0% +$367 0.04% 184
2022
Q2 		$870K Buy
2,481
+291
+13% +$119K 0.04% 165
2022
Q1 		$1.2M Buy
2,190
+80
+4% +$42.1K 0.05% 153
2021
Q4 		$1.39M Sell
2,110
-41
-2% -$25.7K 0.05% 133
2021
Q3 		$1.34M Buy
2,151
+15
+0.7% +$10.1K 0.05% 130
2021
Q2 		$1.35M Hold
2,136
– – 0.05% 125
2021
Q1 		$1.04M Buy
2,136
+10
+0.5% +$5.01K 0.05% 126
2020
Q4 		$1.06M Hold
2,126
– – 0.05% 123
2020
Q3 		$836K Sell
2,126
-57
-3% -$21.1K 0.04% 134
2020
Q2 		$721K Buy
2,183
+47
+2% +$13.6K 0.04% 138
2020
Q1 		$517K Buy
2,136
+534
+33% +$139K 0.03% 157
2019
Q4 		$418K Hold
1,602
– – 0.02% 185
2019
Q3 		$436K Hold
1,602
– – 0.02% 190
2019
Q2 		$441K Hold
1,602
– – 0.03% 192
2019
Q1 		$358K Hold
1,602
– – 0.02% 211
2018
Q4 		$298K Buy
1,602
+100
+7% +$20.5K 0.02% 224
2018
Q3 		$375K Buy
1,502
+510
+51% +$124K 0.02% 231
2018
Q2 		$216K Buy
+992
New +$204K 0.01% 249

Other funds holding IDXX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Boston Financial Management's IDXX Position: Q4 2024 in Review

Boston Financial Management reduced its Idexx Laboratories (IDXX) stake by 6.2% in Q4 2024, selling an estimated $69.3K and leaving 2,391 shares worth $989K. The position accounts for 0.03% of the portfolio, ranked #195.

Boston Financial Management first reported a position in IDXX in Q2 2018 and has held it in 27 quarters since. The position peaked at $1.5M in Q4 2023. 1,124 funds tracked by Wall St. Rank hold IDXX as of Q4 2024.

  • Boston Financial Management held 2,391 shares of Idexx Laboratories worth $989K as of Q4 2024.
  • Boston Financial Management sold 158 Idexx Laboratories shares in Q4 2024, an estimated $69.3K.
  • Idexx Laboratories made up 0.03% of Boston Financial Management's portfolio in Q4 2024, its #195 holding.
  • Boston Financial Management first reported a position in Idexx Laboratories in Q2 2018 and has held it in 27 quarters since.
  • Boston Financial Management's Idexx Laboratories position peaked at $1.5M in Q4 2023.
  • 1,124 funds tracked by Wall St. Rank held Idexx Laboratories as of Q4 2024.

Based on Boston Financial Management's 13F filing for Q4 2024, filed 3 Feb 2025.